- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.25: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: F.59, N.61, P.631
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.149, S.151, W.152
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.657
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.343, S.371
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: F.59, N.61, P.631
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: N.149, S.151, W.152
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: N.709, G.1131
- Chain C: K.795, D.796
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: N.343, S.371
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.616
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: F.59, N.61, P.631
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.149, S.151, W.152
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain A: D.796
- Chain C: N.709, G.1131
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.657
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.343, S.371
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain C: N.616, T.618
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
- Release Date
- 2021-03-24
- Peptides
- Spike glycoprotein: ABC
4-18 heavy chain: DFH
4-18 light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
GH
IE
LG
JI
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cerutti, G. et al., Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe (2021)
- Release Date
- 2021-03-24
- Peptides
- Spike glycoprotein: ABC
4-18 heavy chain: DFH
4-18 light chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
GH
IE
LG
JI
K